Evidence map›Paper›PMID 31497210›Full record

ArticleAmerican journal of translational research2019

Circ_0039569 promotes renal cell carcinoma growth and metastasis by regulating miR-34a-5p/CCL22.

Chengluo Jin, Linmei Shi, Zhexun Li, Wei Liu, Bai Zhao, Yu Qiu, Yakun Zhao, Kunlun Li, Yifei Li, Qingguo Zhu

Open access · greenAbstract read
In one paragraph

Article in American journal of translational research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 54 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Chengluo JinDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Linmei ShiCollege of Public Health, Harbin Medical University Harbin, China.
Zhexun LiDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Wei LiuDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Bai ZhaoDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Yu QiuDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Yakun ZhaoDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Kunlun LiDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Yifei LiDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Qingguo ZhuDepartment of Urology, The Second Affiliate Hospital, Harbin Medical University Harbin, China.
Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circular RNAs (circRNAs) belong to non-coding RNAs and are known as key regulators in gene regulation. CircRNAs involve in the various biological processes of cancer. However, the functions of circRNAs in renal cell carcinoma (RCC) are still not clear. In this study, the circRNA expression profile was performed in the RCC tissues by microarray. There were 35 significantly expressed circRNAs with more than 5 folds from microarray analysis. Hsa_circ_0039569 (circ_0039569) was verified to be up-regulated in RCC and cells compared with the controls by real time RT-PCR. The assays of cellular functions showed that circ_0039569 down-regulation suppressed the proliferation and metastasis of RCC cells. The molecular mechanism of circ_0039569 in RCC cells showed that circ_0039569 promoted RCC progression by up-regulating CCL22 expression via down-regulating miR-34a-5p. Taken together, the study indicated that circ_0039569 played an important role in RCC cell survival and metastasis, which suggested that an oncogenic role of circ_0039569 in RCC progression.

Indexed as

CCL22cell proliferationhsa_circ_0039569metastasismiR-34a-5pRenal cell carcinoma

Identifiers

PMID31497210
PMCPMC6731413
OpenAlexW2985925331

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.